Three prominent Indiana life sciences executives join BioCrossroads Board of Directors
INDIANAPOLIS (January 31, 2019) — BioCrossroads today announces three prominent members of Indiana’s life sciences community have joined its board of directors: Aaron Schacht, executive vice president – Innovation, Regulatory & Business Development, Elanco US Inc.; J.J. Spegele, vice president, global business solutions, Covance Central Laboratory Services; and Dr. Ram Yeleti, executive vice president / chief physician executive, Community Health Network. Schacht leads research & development, regulatory affairs and business development for Elanco Animal Health, following a 25-year career at Lilly in R&D, Strategy and External Innovation roles. Schacht is currently the Chair of the Board of Directors for AgriNovus Indiana, a sister organization to BioCrossroads within the Central Indiana Corporate Partnership. Spegele has held executive leadership roles in operations, laboratory services, general management and information technology for clinical research organizations. He also served as vice president of global business transformation [...]
IBJ: Indiana life sciences companies raise record $115 million in venture capital
The Indianapolis Business Journal's John Russell is reporting that Indiana life sciences companies raised $115 million in venture capital funding in 2018, a three percent jump from 2017 and 133 percent higher than 2015. “The thing that jumped out at me was the variety,” said Brian Stemme, who tracks venture deals for BioCrossroads (CICP's life sciences initiative), pointing to products under development ranging from cancer drugs to tele-health software. [READ MORE] (Sources: IBJ and BioCrossroads)
